Dr. Nirmal Mulye, Chairman
Nirmal Mulye is the founder of Nostrum. With over 20 years of experience in the specialty/generic pharmaceutical industry, Nirmal is responsible for innovation and development of all of Nostrum’s pharmaceutical products, a portfolio of controlled-release technologies. He has over 10 patents to his credit. Prior thereto, Nirmal served in various research and development positions with Forest Laboratories. He received his B.S. in Pharmacy from Bombay University and Ph.D. from Temple University. His current interests are in the area of healthcare and public policy. He is also currently working with several key innovators in the field of alternative energy and fuels.
Michael T Amato, MBA - President & Chief Executive Officer
Michael Amato currently serves as the President and CEO of InspiRx Inc. Born in Brooklyn, New York, Michael earned his MBA from Bedford University in London, UK. He has over 40 years experience in the medical device industry including several key senior management positions at DHD Medical, Trudell Medical International, and Monaghan Medical Corporation. Michael was most recently Senior Vice President of Special Accounts and Professional relations at TMI/MMC. Prior to this he was Vice President of Sales and Marketing at MMC where he helped position them as the worldwide leader with their Valved-holding chambers used with pressurize Meter Dose Inhalers.
Michael also serves on several boards including nonprofit American Respiratory Care Foundation and The Allergy Asthma Network Mothers of Asthmatics. Michael has also served on the US Food and Drug Administration Device Advisory Panel.
Carlton R. Asher, Jr. Esq
Mr. Asher has served as Secretary and General Counsel of InspiRx since its formation and as Secretary and General Counsel for NPLLC and other Nostrum companies. For over thirty years, Mr. Asher has represented business and individual clients in connection with corporate and litigation matters. He has substantial experience in providing counseling to companies engaged in the pharmaceutical and financial services businesses in connection with general corporate matters, stock and asset acquisitions, product licensing and regulatory compliance. Mr. Asher is a member of the New York State Bar, the New York City Bar Association, the American Bar Association (member, Sections on: Litigation and International Law and Practice; member, Committee on Securities Litigation; member, International Litigation Committee); and the Federal Bar Council. Mr. Asher graduated from Brown University and Vanderbilt University School of Law.
Bernard J. Berk
Mr. Berk is a Director of InspiRx and serves as President and Vice Chairman of Nostrum Laboratories, Inc., a subsidiary of NPLLC, the parent company of InspiRx. Mr. Berk has served in the generic pharmaceutical industry beginning with Par Pharmaceuticals, Inc., where he was Senior Vice President of Sales, Marketing and Business Development. Thereafter, Mr. Berk was, respectively, President and Chief Executive Officer of Nale Pharmaceutical Corporation (an Elan affiliate) and Chief Executive Officer and Chairman of publicly traded Elite Pharmaceuticals, Inc. Mr. Berk has also served as President and Chief Executive Officer of Michael Andrews Corporation, a pharmaceutical management consultant firm. Mr. Berk holds a B.S. from New York University.
